Novo Seeds’ portfolio company, IO Biotech, completes oversubscribed EUR 127m Series B financing to accelerate clinical programs in oncology
Novo Seeds, the early-stage investment and company creation team of Novo Holdings, … Continue reading “Novo Seeds’ portfolio company, IO Biotech, completes oversubscribed EUR 127m Series B financing to accelerate clinical programs in oncology”